MAIN ARTICLE
A medical breakthrough creates a new shopping habit
GLP-1-based treatments influence blood-sugar regulation and appetite. Medicines containing semaglutide have substantially improved treatment options for many people living with type 2 diabetes or obesity. But benefits can come with nausea, vomiting, constipation, diarrhea and digestive discomfort. Smaller meals can also make it more difficult to meet nutritional requirements unless patients pay attention to the quality and quantity of what they eat.
Florida emergency nurse Allison Vecchio told Reuters that GLP-1 treatment felt like a chance to reset her life, although symptoms sometimes left her exhausted. She said fiber, collagen and electrolyte products coincided with feeling better and estimated the additional expense at $200 to $300 a month. Her experience matters as a patient account; it does not demonstrate that the same combination will work for others, or that a specific supplement caused the improvement.
The influencer economy enters the medicine cabinet
A Nutrition Business Journal survey cited by Reuters suggested nearly half of GLP-1 users added vitamins or supplements after starting treatment. Boston Consulting Group separately found that users anticipated spending about one-fifth more on protein, fiber and collagen products.















